Literature DB >> 19205798

Molecular characterization of Rhodococcus equi from horse-breeding farms by means of multiplex PCR for the vap gene family.

Fernanda Monego1, Franciele Maboni, Cristina Krewer, Agueda Vargas, Mateus Costa, Elgion Loreto.   

Abstract

This study evaluated the molecular characteristics of Rhodococcus equi isolates obtained from horses by a multiplex PCR assay that amplifies the vap gene family (vapA, -B, -C, -D, -E, -F, -G, and -H). A total of 180 R. equi isolates were studied from four different sources, namely healthy horse feces (112), soil (12), stalls (23), and clinical isolates (33) from horse-breeding farms. The technique was performed and confirmed by sequencing of amplified vap gene family controls. Thirty-two (17.8%) of the R. equi isolates were positive for the vapA gene and carried at least three other vap genes. All 147 isolates from equine feces, stalls, and soil failed to demonstrate any genes associated with virulence-inducing proteins. About 32 (97.0%) out of the 33 clinical equine isolates tested positive for the multiplex PCR assay for the vap gene family. They demonstrated six molecular profiles: 100% featured the vapA, vapD, and vapG genes, 86.6% vapF, 76.6% vapH, 43.3% vapC, 36.6% vapE, and none vapB. The most frequent molecular profile was vap A, -D, -F, G, and -H, where this profile was present in 37.5% of the strains. Moreover, there was no molecular epidemiological pattern for R. equi isolates that uniquely mapped to each horse-breeding farm studied. Our proposed technique allows the identification of eight members of the vap gene family (vapA, B, -C, -D, -E, -F, -G, and -H). It is a practical and efficient method of conducting clinical and epidemiological studies on R. equi isolates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205798     DOI: 10.1007/s00284-009-9370-6

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  26 in total

1.  The Staden package, 1998.

Authors:  R Staden; K F Beal; J K Bonfield
Journal:  Methods Mol Biol       Date:  2000

Review 2.  Pathogenesis and virulence of Rhodococcus equi.

Authors:  M K Hondalus
Journal:  Vet Microbiol       Date:  1997-06-16       Impact factor: 3.293

3.  Cholesterol oxidase (ChoE) is not important in the virulence of Rhodococcus equi.

Authors:  Yanlong Pei; Chris Dupont; Tobias Sydor; Albert Haas; John F Prescott
Journal:  Vet Microbiol       Date:  2006-08-14       Impact factor: 3.293

4.  VapA-negative Rhodococcus equi in a dog with necrotizing pyogranulomatous hepatitis, osteomyelitis, and myositis.

Authors:  G H Cantor; B A Byrne; S A Hines; H M Richards
Journal:  J Vet Diagn Invest       Date:  1998-07       Impact factor: 1.279

5.  VapB-positive Rhodococcus equi infection in an HIV-infected patient in Japan.

Authors:  Yasutaka Mizuno; Fumiya Sato; Mitsuo Sakamoto; Koji Yoshikawa; Masaki Yoshida; Koya Shiba; Shoichi Onodera; Ryoko Matsuura; Shinji Takai
Journal:  J Infect Chemother       Date:  2005-02       Impact factor: 2.211

6.  Identification of Rhodococcus equi using the polymerase chain reaction.

Authors:  K S Bell; J C Philp; N Christofi; D W Aw
Journal:  Lett Appl Microbiol       Date:  1996-08       Impact factor: 2.858

7.  In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals.

Authors:  Stephanie Jacks; Steeve Giguère; John F Prescott
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

8.  Identification of intermediately virulent Rhodococcus equi isolates from pigs.

Authors:  S Takai; N Fukunaga; S Ochiai; Y Imai; Y Sasaki; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Identification of virulent Rhodococcus equi by amplification of gene coding for 15- to 17-kilodalton antigens.

Authors:  S Takai; T Ikeda; Y Sasaki; Y Watanabe; T Ozawa; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

10.  Molecular characterization of Rhodococcus equi Isolates of horse breeding farms from an endemic region in South of Brazil by multiplex PCR.

Authors:  Cristina da Costa Krewer; Dênis Augusto Spricigo; Sônia de Avila Botton; Mateus Matiuzzi da Costa; Irene Schrank; Agueda Castagna de Vargas
Journal:  Braz J Microbiol       Date:  2008-03-01       Impact factor: 2.476

View more
  5 in total

1.  Estimating the Sensitivity and Specificity of Real-Time Quantitative PCR of Fecal Samples for Diagnosis of Rhodococcus equi Pneumonia in Foals.

Authors:  S D Shaw; N D Cohen; M K Chaffin; G P Blodgett; M Syndergaard; D Hurych
Journal:  J Vet Intern Med       Date:  2015-10-05       Impact factor: 3.333

2.  Vaccination of Mice with Virulence-Associated Protein G (VapG) Antigen Confers Partial Protection against Rhodococcus equi Infection through Induced Humoral Immunity.

Authors:  Marcel M Trevisani; Ebert S Hanna; Aline F Oliveira; Silvia A Cardoso; Maria C Roque-Barreira; Sandro G Soares
Journal:  Front Microbiol       Date:  2017-05-11       Impact factor: 5.640

3.  Bronchopneumonia in wild boar (Sus scrofa) caused by Rhodococcus equi carrying the VapB type 8 plasmid.

Authors:  Agueda Castagna de Vargas; Fernanda Monego; Letícia Trevisan Gressler; Sônia de Avila Botton; Andrea Maria Lazzari; Mateus Matiuzzi da Costa; Roselene Ecco; Márcio Garcia Ribeiro; Gustavo Henrique Batista Lara; Shinji Takai
Journal:  BMC Res Notes       Date:  2013-03-25

4.  Genotypic and phenotypic detection of efflux pump in Rhodococcus equi.

Authors:  Letícia Trevisan Gressler; Agueda Castagna de Vargas; Mateus Matiuzzi da Costa; Luciana Pötter; Bibiana Petri da Silveira; Luis Antônio Sangioni; Sônia de Avila Botton
Journal:  Braz J Microbiol       Date:  2014-08-29       Impact factor: 2.476

5.  Use of Serial Quantitative PCR of the vapA Gene of Rhodococcus equi in Feces for Early Detection of R. equi Pneumonia in Foals.

Authors:  R G Madrigal; S D Shaw; L A Witkowski; B E Sisson; G P Blodgett; M K Chaffin; N D Cohen
Journal:  J Vet Intern Med       Date:  2016-01-24       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.